Career history of Oved Amitay
Former positions of Oved Amitay
Companies | Position | Start | End |
---|---|---|---|
The Solve ME/CFS Initiative
The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services The Solve ME/CFS Initiative is a non-profit organization that focuses on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), long COVID, and other post-infection diseases. The non-profit company is based in Glendale, CA. The organization provides answers and links to information for those living with and managing ME/CFS or long COVID. ME/CFS is a chronic, complex, neuroimmune disease that limits the health and productivity of patients and is often triggered by an infection. The organization's advocacy cafe chat series features community members sharing their stories to advocate for change. The Solve ME Research Advisory Council includes professionals from many fields that touch on ME/CFS. The company was founded in 1987. Oved Amitay has been the CEO of the company since 2020. | Director/Board Member | 2020-05-31 | 2023-10-15 |
Chief Executive Officer | 2020-05-31 | 2023-10-15 | |
President | 2020-05-31 | 2023-10-15 | |
CENTOGENE N.V. | Corporate Officer/Principal | 2018-10-31 | 2020-05-30 |
Arrett Neuroscience, Inc. | Chief Operating Officer | 2015-12-31 | 2017-12-31 |
President | 2015-12-31 | 2017-12-31 | |
ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2012-06-26 | 2016-05-31 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 1997-12-31 | 2010-12-31 |
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Peptor Ltd | Corporate Officer/Principal | - | - |
Training of Oved Amitay
The Hebrew University of Jerusalem | Undergraduate Degree |
Northeastern University | Graduate Degree |
Statistics
International
United States | 7 |
Israel | 3 |
Germany | 2 |
Operational
Corporate Officer/Principal | 5 |
President | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
CENTOGENE N.V. | Commercial Services |
Private companies | 5 |
---|---|
Peptor Ltd | Health Technology |
CeNeS Pharmaceuticals, Inc.
CeNeS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals, Inc. discovers and develops proprietary pharmaceuticals to prevent and treat disorders and injuries of the nervous system. The company is headquartered in Cambridge, MA. | Health Technology |
Arrett Neuroscience, Inc. | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
The Solve ME/CFS Initiative
The Solve ME/CFS Initiative Miscellaneous Commercial ServicesCommercial Services The Solve ME/CFS Initiative is a non-profit organization that focuses on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), long COVID, and other post-infection diseases. The non-profit company is based in Glendale, CA. The organization provides answers and links to information for those living with and managing ME/CFS or long COVID. ME/CFS is a chronic, complex, neuroimmune disease that limits the health and productivity of patients and is often triggered by an infection. The organization's advocacy cafe chat series features community members sharing their stories to advocate for change. The Solve ME Research Advisory Council includes professionals from many fields that touch on ME/CFS. The company was founded in 1987. Oved Amitay has been the CEO of the company since 2020. | Commercial Services |
- Stock Market
- Insiders
- Oved Amitay
- Experience